AbbVie Inc.

4AB.DE·XETRA·Healthcare
Compare
252.50−4.50 (−1.75%)today
At close: Oct 21, 5:35 PM CEST · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close257.00
Open256.30
Day range252.50257.50
52-week range162.85259.60
Off day high−1.94%
Off 52-week high−2.73%
Volume524
Avg. volume (3M)586
Market cap446.20B
EPS (TTM)3.03
Forward P/E—
P/E ratio (TTM)83.33
Dividend yield2.40% (6.17)
Beta (5Y)0.23
Shares outstanding1.77B
Short interest—
Earnings dateOct 30, 2026
Analyst target—
Profit margin9.80%

Against its peers

Compare in full ›
4AB.DE BMY PFE AZN LLY AMG.F
Market cap 446.20B 128.10B 171.68B 267.70B 1.17T 214.52B
P/E (TTM) 83.3 13.8 39.6 25.8 43.9 28.8
Forward P/E — 9.5 10.4 15.2 27.7 —
Price/book -84.4 5.7 2.0 5.3 34.4 20.6
Dividend yield 2.40% 4.12% 5.76% 1.90% 0.54% 2.25%
1-year change +29.41% +39.45% +21.00% +0.99% +54.77% +53.67%
Today −1.75% +2.60% +0.91% +2.47% +2.88% +1.72%

The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to AbbVie's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
Bristol-Myers Squibb CompanyBMY · Drug Manufacturers - General 128.10B 62.71 +2.60%
Pfizer Inc.PFE · Drug Manufacturers - GeneralOdds 171.68B 30.12 +0.91%
AstraZeneca PLCAZN · Drug Manufacturers - General 267.70B 172.61 +2.47%
Eli Lilly and CompanyLLY · Drug Manufacturers - GeneralOdds 1.17T 1,307.39 +2.88%
Amgen Inc.AMG.F · Drug Manufacturers - General 214.52B 396.80 +1.72%
Biogen Inc.BIIB · Drug Manufacturers - General 37.00B 250.43 +3.92%
Glenmark Pharmaceuticals LimitedGLENMARK.BO · Drug Manufacturers - Specialty & Generic 616.12B 2,183.10 −0.99%
Camurus AB (publ)CAMX.ST · Biotechnology 39.84B 669.50 −0.07%

Other companies in Drug Manufacturers - General, closest in size first.

Company Mkt cap Price Today
Merck & Co., Inc.MRK · Rahway, NJOdds 357.65B 144.97 −3.28%
Biogen Inc.BIIB.MX · Cambridge, MA 576.36B 3,900.80 0.00%
Roche Holding AGRHO6.F · Basel, Switzerland 332.73B 52.20 −0.36%
Johnson & JohnsonJNJ · New Brunswick, NJ 644.00B 267.23 +3.67%
Novartis AGNVS · Basel, Switzerland 296.17B 155.82 +1.23%
AstraZeneca PLCAZN · Cambridge, United Kingdom 267.70B 172.61 +2.47%
Amgen Inc.AMGN · Thousand Oaks, CA 241.72B 447.11 +2.00%
Gilead Sciences, Inc.GILD · Foster City, CAOdds 192.64B 155.36 +1.17%

Also based in North Chicago, Illinois, then elsewhere in Illinois.

Company Mkt cap Price Today
Deere & CompanyDE · Moline, IL 172.17B 638.54 +0.31%
Abbott LaboratoriesABT · Abbott Park, IL 176.74B 102.14 +1.62%
McDonald's CorporationMCD · Chicago, ILOdds 177.58B 250.95 +1.91%
United Airlines Holdings, Inc.UAL · Chicago, ILOdds 33.14B 102.12 +0.44%
Mondelez International, Inc.MDLZ · Chicago, IL 82.62B 64.73 +3.17%
Motorola Solutions, Inc.MSI · Chicago, IL 78.21B 472.59 +1.09%
Ventas, Inc.VTR · Chicago, IL 44.39B 86.53 +1.35%
Archer-Daniels-Midland CompanyADM · Chicago, IL 38.19B 79.23 −0.16%

The stocks whose daily moves over the past year went most closely with AbbVie's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
Johnson & JohnsonJNJ.DE · Correlation 0.51 571.87B 237.30 +4.38%

What visitors to AbbVie's page also look at.

Company Mkt cap Price Today
JOHNSON & JOHNSONJNJ.DE 571.87B 237.30 +4.38%
PEPSICO INC.PEP.DE 167.78B 123.12 +2.34%
PROCTER & GAMBLE CO., THEPRG.DE 345.29B 148.66 +5.54%
COCA-COLA CO., THECCC3.DE 363.22B 84.42 +1.98%
VERIZON COMMUNICATIONS INC.BAC.DE 165.69B 39.88 +3.13%

From the 4Conservative instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All 4AB.DE news ›
The Globe and Mail·Positive

AbbVie's Neuroscience Franchise: What to Expect Ahead of Q3 Results

The Zacks Consensus Estimate for AbbVie’s neuroscience revenues in the third quarter of 2026 is pegged at $3.29 billion. The figure implies year-over-year growth of nearly 16%, with growth expected across most marketed products. Turning to…

From articles in the 4Search news index.

In the news

201mentions in 30 days
201with it in the headline
Positivesentiment

Mentioned with

Pfizer149Eli Lilly124Johnson & Johnson108Bristol Myers Squibb107Abbvie Inc.99Novo Nordisk76Abbott Laboratories68Apogee Therapeutics63

People in the coverage

Abbvie173Rinvoq131Skyrizi120Bristol Myers64Vyalev57Robert Michael51

Themes

Abbv134Jnj92Lly85Stock Market66Healthcare56Pharma52Usmf-Health-Care52Finance & Insurance48

Most coverage from

  1. theglobeandmail.com37
  2. marketscreener.com17
  3. gurufocus.com14
  4. fool.com13
  5. tradingview.com10

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.